This week we look at how changes to accelerated approvals at the Food and Drug Administration are affecting drug approvals. Also, there is news of CVS’s foray into clinical trials, the end of the public health emergency for COVID-19, and the costs of the Supreme Court not hearing a case involving generic drugs. … READ MORE >
5 things to know in life sciences: Week of May 8, 2023
From exploring the use of AI in drug discovery to new guidance on decentralized trials, each week we highlight what’s happening in the life sciences industry. … READ MORE >